Sintilimab
Product Specifications
CAS Number
2072873-06-2
Target
PD-1/PD-L1
Related Pathways
Cell Cycle/Checkpoint, Apoptosis, Immunology/Inflammation
Purity
>95%
Bioactivity
Sintilimab (IBI308) is a humanized IgG4 monoclonal antibody with significant anti-tumor activity that restores endogenous anti-tumor T-cell responses by binding to PD-1 and thereby blocking the interaction of PD-1 with its ligands (PD-L1 and PL-L2) .Sintilimab is used in combination with other compounds for the treatment of classical Hodgkin's lymphoma, non-cellular lung cancer and esophageal cancer. Sintilimab is used in combination with other compounds to treat classical Hodgkin's lymphoma, non-small cell lung cancer and esophageal cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
049100-01 10 µg
Tyrosine Phosphatase Receptor Type B (PTPRB), Recombinant, Rat, His-Tag
Sign In for Pricing
View Details 049100-02 50 µg
Tyrosine Phosphatase Receptor Type B (PTPRB), Recombinant, Rat, His-Tag
Sign In for Pricing
View Details 049100-03 100 µg
Tyrosine Phosphatase Receptor Type B (PTPRB), Recombinant, Rat, His-Tag
Sign In for Pricing
View Details 049100-04 200 µg
Tyrosine Phosphatase Receptor Type B (PTPRB), Recombinant, Rat, His-Tag
Sign In for Pricing
View Details ABC-X0131C 1 Vial
XpressTM Mouse SIRPA Over-expressing Cell Line (CHOK1)
Sign In for Pricing
View Details 